Atlas Trials

Trial of Surufatinib Combined With JS001 in the Treatment of Advanced Solid Tumors

Clinical trial NCT03879057 · UNKNOWN

Trial details

NCT number
NCT03879057
Sponsor
Peking University
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Solid Tumor
Start date
2018-12-21
Primary completion
2020-12-20
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.